BELMONT, Calif. and HYDERABAD, India, July 20, 2011 /PRNewswire/
— Ventus Medical is pleased to announce the Indian launch of its
proprietary Provent® Sleep Apnea Therapy, an innovative,
non-invasive treatment for obstructive sleep apnea (OSA). Orbees
Business Solutions Pvt. Ltd. will be the strategic market developer
of Provent Therapy in India.
(Logo: http://photos.prnewswire.com/prnh/20110209/SF45785-a)
(Logo: http://photos.prnewswire.com/prnh/20110209/SF45785-b)
“India has a very high prevalence of obstructive sleep apnea.
Roughly 20% of urban Indian males suffer from OSA,” said Rajiv
Doshi, M.D., Chief Scientific Officer of Ventus Medical and
inventor of the Provent technology. Dr. Doshi is faculty at
Stanford University and serves as Executive Director (US) of the
Stanford India Biodesign program, a Government of India funded
collaboration between Stanford University and the All India
Institute of Medical Sciences (AIIMS) and the Indian Institute of
Technology Delhi. “With a very large patient need, we believe that
Provent Therapy provides a reliable and clinically-proven solution
to treat the millions of people in India with OSA.”
In patients with OSA the airway collapses during sleep when the
muscles that hold it open relax. People with this disorder stop
breathing during the night—in some cases hundreds of times each
night—usually for periods of ten seconds or longer. Sleep apnea
can lead to fatigue, early morning headaches, irritability, lack of
concentration, and contributes to depression, learning and memory
difficulties, and sexual dysfunction. Importantly, many recent
studies have shown that OSA is associated with high blood pressure,
irregular heartbeat, heart attack, stroke and diabetes.
“Many people in India go undiagnosed and very few receive
treatment due
‘/>”/>
SOURCE
